Baker Biotech Capital (GP), LLC Insider Trading $VPHM VIROPHARMA INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Baker Biotech Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Biotech Capital (GP), LLC. Baker Biotech Capital (GP), LLC is 10% Owner in PHARMACYCLICS INC ($PCYC) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in ADOLOR CORP ($ADLR) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in Ocera Therapeutics, Inc. ($TZYM).
Baker Biotech Capital (GP), LLC in VIROPHARMA INC
Trading Symbol: VPHMIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Biotech Capital (GP), LLC: 10% Owner
Holdings: 1,966,090 shares
Latest Transaction: Dec 16 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Baker Biotech Capital (GP), LLC in VIROPHARMA INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, GHDX, TZYM, PCYC, SGEN, GEVA, VPHM
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 16 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 27.29 | 50,566 | 1,379,860 | 1,966,090 | 1.9 M to 2 M (+2.64 %) |
Oct 06 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 18.18 | 16,278 | 295,985 | 1,915,524 | 1.9 M to 1.9 M (+0.86 %) |
Oct 06 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 17.48 | 2,511 | 43,883 | 1,899,246 | 1.9 M to 1.9 M (+0.13 %) |
Oct 03 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 18.08 | 13,576 | 245,450 | 1,896,735 | 1.9 M to 1.9 M (+0.72 %) |
Oct 03 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 18.19 | 6,634 | 120,690 | 1,883,159 | 1.9 M to 1.9 M (+0.35 %) |
Oct 03 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 18.00 | 21,117 | 380,089 | 1,876,525 | 1.9 M to 1.9 M (+1.14 %) |
Oct 03 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 17.97 | 11,878 | 213,399 | 1,855,408 | 1.8 M to 1.9 M (+0.64 %) |
Sep 26 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 18.13 | 4,697 | 85,155 | 1,843,530 | 1.8 M to 1.8 M (+0.26 %) |
Sep 26 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 18.13 | 22,084 | 400,295 | 1,838,833 | 1.8 M to 1.8 M (+1.22 %) |
Sep 26 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 17.78 | 8,828 | 156,988 | 1,816,749 | 1.8 M to 1.8 M (+0.49 %) |
Sep 26 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 17.74 | 25,753 | 456,750 | 1,807,921 | 1.8 M to 1.8 M (+1.45 %) |
Sep 26 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 17.58 | 2,147 | 37,753 | 1,782,168 | 1.8 M to 1.8 M (+0.12 %) |
Sep 26 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 17.43 | 9,340 | 162,759 | 1,780,021 | 1.8 M to 1.8 M (+0.53 %) |
Aug 25 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 16.97 | 5,468 | 92,814 | 1,770,681 | 1.8 M to 1.8 M (+0.31 %) |
Page: 1